Product image of Faslodex (Fulvestrant) supplied by GNH India

Faslodex

Active Ingredient:
Fulvestrant
Origin:
EU

Faslodex (Fulvestrant)

Faslodex (Fulvestrant) is an intramuscular injection used for hormone receptor-positive breast cancer treatment. This medication is designed to block estrogen receptors, helping manage advanced breast cancer in postmenopausal women.

Manufacturer / TM Owner

Astrazeneca Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Faslodex is primarily used in the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It is often prescribed for those who have progressed after other hormone therapies. The medication works by binding to estrogen receptors, effectively blocking their activity and slowing the growth of cancer cells.

Side Effects

  • Common effects of Faslodex may include injection site reactions, such as pain, swelling, or redness. Some individuals might experience fatigue, nausea, or headaches. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

  • Faslodex should be administered by a healthcare professional to ensure proper intramuscular injection. It is important to inform your healthcare provider about any allergies or medical conditions before starting treatment. Regular monitoring may be required to assess the medication's effectiveness and any potential side effects.

Avoid Interactions

  • Faslodex may interact with other medications, including those metabolized by certain liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed, as it may affect the overall treatment plan.

Frequently Asked Questions

Faslodex is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women who have progressed after other hormone therapies.

Faslodex is administered as an intramuscular injection, typically by a healthcare professional.

Common side effects include injection site reactions, fatigue, nausea, and headaches.

Faslodex may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Faslodex should be used under the supervision of a healthcare provider, who can assess individual health conditions and potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fulvestrant

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT